Discordance between ambulatory versus clinic blood pressure according to global cardiovascular risk group |
Shin, Jinho
(Department of Internal Medicine, Hanyang University College of Medicine)
Park, Sung Ha (Department of Internal Medicine, Yonsei University College of Medicine) Kim, Ju Han (Department of Internal Medicine, Chonnam National University Medical School) Ihm, Sang Hyun (Department of Internal Medicine, College of Medicine, Bucheon St. Mary's Hospital, The Catholic University of Korea) Kim, Kwang-il (Department of Internal Medicine, Seoul National University Bundang Hospital) Kim, Woo Shik (Department of Internal Medicine, Kyung Hee University School of Medicine) Pyun, Wook Bum (Department of Internal Medicine, Ewha Womans University School of Medicine) Kim, Yu-Mi (Department of Preventive Medicine, Dong-A University College of Medicine) Choi, Sung-il (Department of Internal Medicine, Hanyang University College of Medicine) Kim, Soon Kil (Department of Internal Medicine, Hanyang University College of Medicine) |
1 | European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-1053. DOI |
2 | Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-1187. DOI |
3 | Park SH, Yoon JS, Won KC, Lee HW. Usefulness of glycated hemoglobin as diagnostic criteria for metabolic syndrome. J Korean Med Sci 2012;27:1057-1061. DOI |
4 | Franklin SS, Thijs L, Hansen TW, et al. Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population. Hypertension 2012;59:564-571. DOI |
5 | Hwang ES, Choi KJ, Kang DH, et al. Prevalence, predictive factor, and clinical significance of white-coat hypertension and masked hypertension in Korean hypertensive patients. Korean J Intern Med 2007;22:256-262. DOI |
6 | Segura J, Banegas JR, Ruilope LM. Usefulness of ambulatory blood pressure monitoring (ABPM) in daily clinical practice: data from the Spanish ABPM registry. Clin Exp Pharmacol Physiol 2014;41:30-36. DOI |
7 | Banegas JR, Ruilope LM, de la Sierra A, et al. High prevalence of masked uncontrolled hypertension in people with treated hypertension. Eur Heart J 2014;35:3304-3312. DOI |
8 | Bobrie G, Clerson P, Menard J, Postel-Vinay N, Chatellier G, Plouin PF. Masked hypertension: a systematic review. J Hypertens 2008;26:1715-1725. DOI |
9 | Yoon HJ, Ahn Y, Park JB, et al. Are metabolic risk factors and target organ damage more frequent in masked hypertension than in white coat hypertension? Clin Exp Hypertens 2010;32:480-485. DOI |
10 | Celis H, Fagard RH. White-coat hypertension: a clinical review. Eur J Intern Med 2004;15:348-357. DOI |
11 | Park SJ, Park JB, Choi DJ, et al. Detection of masked hypertension and the ‘mask effect' in patients with well-controlled office blood pressure. Circ J 2011;75:357-365. DOI |
12 | Modolo R, Ruggeri Barbaro N, de Faria AP, et al. The white-coat effect is an independent predictor of myocardial ischemia in resistant hypertension. Blood Press 2014;23:276-280. DOI |
13 | Myers MG. Pseudoresistant hypertension attributed to white-coat effect. Hypertension 2012;59:532-533. DOI |
14 | Vongpatanasin W. Resistant hypertension: a review of diagnosis and management. JAMA 2014;311:2216-2224. DOI |
15 | Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010;375:938-948. DOI |
16 | Boggia J, Li Y, Thijs L, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 2007;370:1219-1229. DOI |
17 | Dawes MG, Coats AJ, Juszczak E. Daytime ambulatory systolic blood pressure is more effective at predicting mortality than clinic blood pressure. Blood Press Monit 2006;11:111-118. DOI |
18 | Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 2005;46:156-161. DOI |
19 | Mesquita-Bastos J, Bertoquini S, Polonia J. Cardiovascular prognostic value of ambulatory blood pressure monitoring in a Portuguese hypertensive population followed up for 8.2 years. Blood Press Monit 2010;15:240-246. DOI |
20 | Kikuya M, Hansen TW, Thijs L, et al. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation 2007;115:2145-2152. DOI |
21 | Thijs L, Hansen TW, Kikuya M, et al. The International Database of Ambulatory Blood Pressure in relation to Cardiovascular Outcome (IDACO): protocol and research perspectives. Blood Press Monit 2007;12:255-262. DOI |
22 | National Clinical Guideline Centre. Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines. London: NICE (National Institute of Clinical Excellence), 2011. |
23 | Taylor PJ. Evidence for key recommendation in NICE guidance on hypertension is poor. BMJ 2011;343:d6494. DOI |
24 | Verdecchia P, Angeli F, Cavallini C. Ambulatory blood pressure for cardiovascular risk stratification. Circulation 2007;115:2091-2093. DOI |
25 | Staessen J, Fagard R, Lijnen P, Thijs L, van Hoof R, Amery A. Ambulatory blood pressure monitoring in clinical trials. J Hypertens Suppl 1991;9:S13-S19. DOI |
![]() |